We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Multiple-Organ Failure Main Cause of ICU Death

By HospiMedica staff writers
Posted on 14 Nov 2006
A new study has found that multiple-organ failure and malignant tumors are the main causes of death in the intensive care unit (ICU) and in the hospital.

Researchers from the Innsbruck Medical University (Austria) collaborated with colleagues from other institutions in Austria to analyze the cause of death in 3,700 patients admitted to ICUs. More...
The researchers focused on the causes of death in the ICU, in the hospital after discharge from the ICU, and one year after admission to the ICU.

The results showed that 47% of patients who died in the ICU died as a result of multiple-organ dysfunction syndrome (MODS). Acute and chronic multiple-organ dysfunction were much more common causes of death in the ICU than single organ failure. In addition, patients with central nervous system failure had a 16.07% increased risk of dying while in the ICU, and patients with cardiovascular failure had an almost 12% risk of dying. Malignant tumor disease caused over a third of hospital deaths in patients who had been discharged from the ICU, one year after admission to the ICU.

Exacerbation of chronic cardiovascular disease caused 19.4% of deaths after discharge from the ICU and it is the second most-frequent cause of death both after discharge from the ICU and one year after admission to the ICU. The results were published in the November 3, 2006, online edition of the journal Critical Care.

"Acute or chronic MODS prevails by far over single-organ failure or unexpected cardiac arrest as cause of death in the ICU,” wrote Dr. Viktoria D. Mayer and colleagues. "To improve short- and long-term outcomes of critically ill patients, treatment and research should focus on effective therapy of central nervous system failure and cardiovascular failure, as well as on prevention of re-admission to the ICU.”



Related Links:
Innsbruck Medical University

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mammo DR Retrofit Solution
DR Retrofit Mammography
Mobile X-Ray System
K4W
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.